People's United Financial’s Neurocrine Biosciences NBIX Stock Holding History

People's United Financial’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$802K	Buy	8,555 +644	+8%	+$54.6K	0.02%	362
2021 Q4	$674K	Sell	7,911 -99	-1%	-$9.11K	0.02%	432
2021 Q3	$768K	Sell	8,010 -191	-2%	-$18K	0.02%	433
2021 Q2	$798K	Buy	8,201 +254	+3%	+$24.3K	0.02%	428
2021 Q1	$773K	Buy	7,947 +87	+1%	+$9.12K	0.02%	407
2020 Q4	$753K	Buy	7,860 +84	+1%	+$8.11K	0.02%	384
2020 Q3	$748K	Sell	7,776 -11	-0.1%	-$1.27K	0.02%	348
2020 Q2	$950K	Buy	7,787 +1,630	+26%	+$180K	0.03%	297
2020 Q1	$533K	Buy	6,157 +275	+5%	+$26.9K	0.02%	363
2019 Q4	$632K	Buy	5,882 +103	+2%	+$10.8K	0.02%	447
2019 Q3	$521K	Sell	5,779 -189	-3%	-$17.7K	0.01%	514
2019 Q2	$504K	Sell	5,968 -4,523	-43%	-$371K	0.01%	545
2019 Q1	$924K	Buy	+10,491	New	+$877K	0.03%	406

Other funds holding NBIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

People's United Financial's NBIX Position: Q1 2022 in Review

People's United Financial increased its Neurocrine Biosciences (NBIX) stake by 8.1% in Q1 2022, buying an estimated $54.6K and bringing the position to 8,555 shares worth $802K. The position accounts for 0.02% of the portfolio, ranked #362.

People's United Financial first reported a position in NBIX in Q1 2019 and has held it in 13 quarters since. The position peaked at $950K in Q2 2020. 427 funds tracked by Wall St. Rank hold NBIX as of Q1 2022.

People's United Financial held 8,555 shares of Neurocrine Biosciences worth $802K as of Q1 2022.
People's United Financial bought 644 Neurocrine Biosciences shares in Q1 2022, an estimated $54.6K.
Neurocrine Biosciences made up 0.02% of People's United Financial's portfolio in Q1 2022, its #362 holding.
People's United Financial first reported a position in Neurocrine Biosciences in Q1 2019 and has held it in 13 quarters since.
People's United Financial's Neurocrine Biosciences position peaked at $950K in Q2 2020.
427 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2022.

Based on People's United Financial's 13F filing for Q1 2022, filed 10 May 2022.